~ COVID-19 Medical News ~

Medical News on therapies and treatments being investigated:

May 30, 2020 - Hdroxychloroquine UPDATE - Scientists Worldwide Are Questioning A Massive

                                                              Study That Raised Concerns About The COVID-19 Treatment.

May 27, 2020 Hdroxychloroquine UPDATE - EU governments ban malaria drug for COVID-19,

                                                                                    trial paused as safety fears grow.

May 26, 2020 - Novavax begins human trials for COVID-19 vaccine in Australia

May 26, 2020 - Merck Chairman and CEO

Kenneth Frazier

May 21, 2020 - Dr.Paul Stoffels, Johnson & Johnson

Vice Chairman, Status of J&J's Vaccine

May 20, 2020 - New research shows that diabetes medications could treat COVID-19 in diabetes patients

May 15, 2020 - Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced today that its anti-SARS-CoV-2 antibody, STI-1499, demonstrated 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very low antibody concentration.

  • Hdroxychloroquine​ - An old (since the 1930's) anti-malarial drug is now in clinical trials all over the world and has shown to be effective in eliminating the COVID-19 virus from the body.  BUT only time will tell if this drug will be a true effective solution until a vaccine can be fully developed.

       That said, Teva says it will donate 6 million doses of hydroxychloroquine sulfate tablets

       tablets through wholesalers to hospitals by March 31. We expect them to be widely

       available in mid-April.

       May 14, 2020 Update - NIH begins clinical trial of hydroxychloroquine and azithromycin

                                                  to treat COVID-19

* * The projected time for a fully tested vaccine is Spring of 2021. * *

  • Remdesivir has been studied for years as an experimental antiviral, most recently for its potential against Ebola.  Doctors were throwing it against COVID-19 in a "try something" approach, to the point that demand led its manufacturer, Gilead (GILD), to limit its used to clinical trials. Six large studies are ongoing. The first should report results on April 3, the second in mid-April, and two more in May.

       UPDATE - May 2, 2020  FDA Approves Emergency Use 


          May 18, 2020 Early data show Moderna Covid-19 vaccine generates immune